Delaware Chancery Court Dismisses Cigna Derivative Suit Over Failed Anthem Merger; The PCAOB Sanctions Former KPMG Vice Chair Of Audit For Failure To Supervise Senior Members Of KPMG's Audit Practice; Ninth Circuit Affirms...more
4/21/2022
/ Anthem Insurance ,
Board of Directors ,
Breach of Contract ,
Breach of Duty ,
CEOs ,
CIGNA ,
Civil Monetary Penalty ,
Class Action ,
Coronavirus/COVID-19 ,
Derivative Suit ,
Disgorgement ,
Dismissals ,
False Statements ,
Fiduciary Duty ,
KPMG ,
Material Misstatements ,
Mergers ,
Misleading Statements ,
Omissions ,
PCAOB ,
Publicly-Traded Companies ,
Putative Class Actions ,
Sanctions ,
Sarbanes-Oxley ,
Scienter ,
Securities Exchange Act of 1934 ,
Securities Litigation ,
Securities Transactions ,
Securities Violations ,
Shareholders ,
Short-Swing Trading
Northern District of Illinois Grants Motion for Partial Reconsideration of Summary Judgment Decision Regarding Whether Former Walgreens CFO’s Statements Were Actionable; Securities Fraud Claims Against Chicken Producer for...more
3/23/2022
/ Antitrust Violations ,
Bid Rigging ,
Bristol-Myers Squibb ,
CEOs ,
CFOs ,
Class Action ,
Clinical Trials ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Dismissal With Prejudice ,
Dismissals ,
False Statements ,
Guilty Pleas ,
Investors ,
Misleading Statements ,
Partial Summary Judgments ,
Pharmaceutical Industry ,
Price-Fixing ,
Private Securities Litigation Reform Act of 1995 ,
PSLRA ,
Public Statements ,
Safe Harbors ,
Scienter ,
Securities Exchange Act of 1934 ,
Securities Fraud ,
Securities Litigation ,
Securities Violations ,
Share Price ,
Stock Drop Litigation ,
Walgreens
Delaware Federal Court Dismisses Shareholder Derivative Suit Concerning Lack of Board Diversity; California Federal Court Dismisses Shareholder Class Action Against Sorrento Therapeutics Regarding COVID-19 Treatment; Delaware...more
12/23/2021
/ Board of Directors ,
Cannabis-Related Businesses (CRBs) ,
Class Action ,
Coronavirus/COVID-19 ,
Derivative Suit ,
Discovery ,
Discovery Violations ,
Dismissals ,
Diversity ,
False Statements ,
Investment Fraud ,
Investors ,
Misleading Statements ,
Misrepresentation ,
Pharmaceutical Industry ,
Popular ,
Putative Class Actions ,
Rule 10b-5 ,
Scienter ,
Securities Exchange Act of 1934 ,
Securities Violations ,
Shareholder Litigation ,
Shareholders
New York Federal Court Dismisses Securities Fraud Claims Against Alkermes for Lack of Fraudulent Intent; Fourth Circuit Affirms District Court’s Denial of Leave to File Amended Complaint Against Triangle Capital as Futile;...more
3/11/2021
/ Amended Complaints ,
Appeals ,
Class Action ,
D&O Insurance ,
DE Supreme Court ,
Dismissals ,
Investors ,
Mergers ,
Misrepresentation ,
Putative Class Actions ,
Scienter ,
Securities Fraud ,
Securities Litigation ,
Securities Transactions ,
Securities Violations ,
Subpoenas ,
Work-Product Doctrine